Kemnay Advisory Services’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Kemnay Advisory Services's RYTM Position: Q3 2026 in Review
Kemnay Advisory Services increased its Rhythm Pharmaceuticals (RYTM) stake by 6.7% in Q3 2026, buying an estimated $4.38K and bringing the position to 657 shares worth $62.6K. The position accounts for 0.01% of the portfolio, ranked #241.
Kemnay Advisory Services first reported a position in RYTM in Q4 2025 and has held it in 4 quarters since. The position peaked at $68.4K in Q2 2026. 333 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Kemnay Advisory Services held 657 shares of Rhythm Pharmaceuticals worth $62.6K as of Q3 2026.
- Kemnay Advisory Services bought 41 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $4.38K.
- Rhythm Pharmaceuticals made up 0.01% of Kemnay Advisory Services's portfolio in Q3 2026, its #241 holding.
- Kemnay Advisory Services first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- Kemnay Advisory Services's Rhythm Pharmaceuticals position peaked at $68.4K in Q2 2026.
- 333 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Kemnay Advisory Services's 13F filing for Q3 2026, filed 16 Nov 2026.